Latest Insider Transactions at Inari Medical, Inc. (NARI)
This section provides a real-time view of insider transactions for Inari Medical, Inc. (NARI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inari Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inari Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-0.79%
|
$5,760,000
$96.42 P/Share
|
|
Mar 07
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+5.01%
|
$0
$0.43 P/Share
|
|
Mar 03
2022
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-5.41%
|
-
|
|
Mar 01
2022
|
Robert Keith Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,191
+50.0%
|
-
|
|
Mar 01
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
13,696
-1.03%
|
$1,232,640
$90.74 P/Share
|
|
Mar 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2
-0.0%
|
$180
$90.0 P/Share
|
|
Mar 01
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2
+0.0%
|
$0
$0.46 P/Share
|
|
Feb 28
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
6,304
-1.79%
|
$567,360
$90.05 P/Share
|
|
Feb 28
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,998
-2.46%
|
$359,820
$90.01 P/Share
|
|
Feb 28
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,998
+4.63%
|
$0
$0.46 P/Share
|
|
Feb 24
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
4,172
-0.05%
|
$333,760
$80.06 P/Share
|
|
Feb 23
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
100
-0.0%
|
$8,000
$80.0 P/Share
|
|
Feb 17
2022
|
Thomas Tu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,936
+20.3%
|
-
|
|
Feb 17
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,936
+18.52%
|
-
|
|
Feb 17
2022
|
Andrew Hykes President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,879
+14.37%
|
-
|
|
Feb 17
2022
|
William Hoffman Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,708
+6.98%
|
-
|
|
Feb 16
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
8,993
-0.23%
|
$719,440
$80.06 P/Share
|
|
Feb 15
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-5.11%
|
$592,500
$79.04 P/Share
|
|
Feb 15
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.06%
|
$0
$0.46 P/Share
|
|
Feb 15
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
335
-0.01%
|
$26,800
$80.01 P/Share
|
|
Feb 09
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
400
-0.01%
|
$32,000
$80.06 P/Share
|
|
Feb 07
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.34%
|
$2,190,000
$73.48 P/Share
|
|
Feb 07
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+5.03%
|
$0
$0.43 P/Share
|
|
Feb 01
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.83%
|
$370,000
$74.08 P/Share
|
|
Jan 18
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.8%
|
$380,000
$76.91 P/Share
|
|
Jan 18
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.59%
|
$570,000
$76.9 P/Share
|
|
Jan 18
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.1%
|
$0
$0.46 P/Share
|
|
Jan 04
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.92%
|
$2,850,000
$95.58 P/Share
|
|
Jan 01
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-0.4%
|
$24,934
$91.27 P/Share
|
|
Jan 01
2022
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
411
-0.3%
|
$37,401
$91.27 P/Share
|
|
Jan 01
2022
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
548
-0.11%
|
$49,868
$91.27 P/Share
|
|
Jan 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-0.47%
|
$24,934
$91.27 P/Share
|
|
Dec 15
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-6.17%
|
$1,580,000
$79.04 P/Share
|
|
Dec 15
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
22,222
-13.9%
|
-
|
|
Dec 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$553,000
$79.4 P/Share
|
|
Dec 06
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-1.66%
|
$4,680,000
$78.0 P/Share
|
|
Nov 29
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.02%
|
$415,000
$83.2 P/Share
|
|
Nov 29
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.29%
|
$0
$0.46 P/Share
|
|
Nov 15
2021
|
Jonathan D Root Director |
BUY
Open market or private purchase
|
Indirect |
303
+47.49%
|
$26,967
$89.08 P/Share
|
|
Nov 15
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.2%
|
$30,000
$3.46 P/Share
|
|
Nov 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$644,000
$92.84 P/Share
|
|
Nov 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.72%
|
$430,000
$86.98 P/Share
|
|
Nov 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.12%
|
$0
$0.46 P/Share
|
|
Nov 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.07%
|
$2,760,000
$92.26 P/Share
|
|
Oct 28
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
3,722
-0.65%
|
$334,980
$90.17 P/Share
|
|
Oct 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.72%
|
$435,000
$88.0 P/Share
|
|
Oct 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.53%
|
$0
$0.46 P/Share
|
|
Oct 25
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
500
-0.09%
|
$45,000
$90.05 P/Share
|
|
Oct 20
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,778
-4.29%
|
$2,320,020
$90.1 P/Share
|
|
Oct 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-1.35%
|
$783,000
$87.49 P/Share
|